Novel Drug Candidate Based on HSS Research Secures $70M Series A Financing and Will Begin Its First

SciRhom GmbH, a biotech startup co-founded by Hospital for Special Surgery (HSS), recently secured a 63 million euro (US$70 million) Series A financing round ... Read more

Bron:

Newswise: Latest News